Data protection Impressum

Healthcare

Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug development.

Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment

9 April 2024

Sitem Startup Club (SSC) has officialized a partnership with CSEM, uniting Bern's medtech ecosystem with engineering excellence for transformative healthcare solutions.

Sitem Startup Club and CSEM forge a strategic partnership to propel medtech innovation

8 April 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (March 2024)

26 March 2024

This financial infusion is set to bolster the clinical advancement of Volumina Medical’s injectable dermal filler, Adipearl.

Volumina Medical raises USD 21 million to advance regenerative medicine

25 March 2024

This funding follows closely on the heels of the completion of enrollment of Spineart’s BAGUERA® C Intervertebral Disc (IDE) studies, which aim to push the boundaries of spinal surgery through extensive research and development efforts.

Spineart raises CHF 20 million to push the boundaries of spinal surgery

20 March 2024

The ARTORG team investigates how a special balloon catheter must be used so that drugs can reach and dissolve blood clots in the smallest branches. To do this, they combine engineering know-how, fluid mechanics and biological expertise.

Bern researchers unveil groundbreaking cardiac care method

19 March 2024

Neuria not only offers a promising solution for behavioral modification but also provides extensive services to health-related companies and the scientific community.

Neuria enters Vanguard Accelerator to gameify healthier lifestyles

12 March 2024

SmellRS is developing an ambitious and innovative technology for the early detection of Alzheimer's disease and the restoration of the sense of smell.

FONGIT Innovation Fund backs HeroSupport and SmellRS to advance healthcare innovation

4 March 2024

This alliance between Atinary and Takeda is a shining example of how technology and healthcare can come together to create innovative solutions that address pressing challenges in drug development.

Atinary and Takeda forge a strategic alliance to advance healthcare innovation

19 February 2024

This significant financial backing underscores the potential of Alys's comprehensive pipeline targeting a broad spectrum of dermatological indications, from atopic dermatitis to psoriasis.

Alys Pharmaceuticals launches in Geneva with USD 100 million investment

19 February 2024

1 … 14 15 16 17 18 19 20 21 22 … 24